Lunaphore announces dinner reception with industry leaders and data presentation at the AACR Annual Meeting 2022

Lunaphore announces dinner reception with industry leaders and data presentation at the AACR Annual Meeting 2022

LAUSANNE, Switzerland – March 22, 2022 – 3:00 pm (CET)Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced a series of activities, including a dinner reception, a data presentation, and product demonstrations at the American Association for Cancer Research (AACR) Annual Meeting 2022, taking place April 8-13 in New Orleans, Louisiana. The company will host a dinner reception featuring presentations and discussions with leading academic physicians, industry researchers, as well as the Lunaphore leadership team. The company will also hold a spotlight theater on streamlined high-throughput, high-plex immunofluorescence assays and present new data from a recent study that combined hyperplex imaging on the COMET™ PA platform with machine learning clustering analysis to analyze the tumor microenvironment.


Lunaphore Dinner Reception

Date and time: April 11, 2022, 6:30 p.m. CST

Location: Renaissance New Orleans Arts Hotel, 700 Tchoupitoulas St, New Orleans, LA 70130


  • Dr. Janis Taube, Director, Division of Dermatopathology and Professor of Dermatology, John Hopkins University;
  • Dr. Michael Surace, Associate Director, AstraZeneca;
  • Dr. Carlo Bifulco, Director of Translational Molecular Pathology and Molecular Genomics, Earle A. Chiles Research Institute
  • Deborah Heintze, Co-founder & CMO, Lunaphore;
  • Dr. Diego Dupouy, Co-founder & CTO, Lunaphore;
  • Dr. Everton Robinson, Vice President Sales and Customer Support, Lunaphore.

Register here to reserve a seat at the dinner reception:


Poster Presentation

Mapping the cellular architecture of the tumor microenvironment by integrating hyperplex immunofluorescence and automated image analysis

Date and time: April 11, 2022, 1:30 p.m. CST

Location: Poster Section 15


  • Dr. Pedro Machado, Application Development Scientist, Lunaphore


Exhibitor Spotlight Theater

Streamline your high-throughput, high-plex immunofluorescence assays

Date and time: April 12, 2022, 10:00 p.m. CST

Location: Theatre B


  • Dr. Diego Dupouy, Co-founder & CTO, Lunaphore;
  • Dr. Saska Brajkovic, Vice President Assays and Reagents Development, Lunaphore;
  • Emilie Peres, Application Development Engineer, Lunaphore.


Meet the Expert – Product Demonstrations

Lunaphore will host live demonstrations of its LabSat® and COMET™ spatial biology solutions at booth #1806.


To book a meeting with the Lunaphore team, or find out more about the activities on-site, please visit:



About Lunaphore

Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. For further information on Lunaphore and its products, please visit



For further information contact:


Irene Tamayo

Lunaphore Corporate Communications

Email: [email protected]